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Background
Congenital heart disease (CHD) is associated with in
utero brain dysmaturation and abnormal cerebral vascu-
lature [1,2]. Phase contrast (PC) MRI allows non-inva-
sive quantification of cerebral blood flow (CBF) and,
combined with arterial oxygen saturation (SaO2) and
haemoglobin (Hgb) concentration, can measure cerebral
oxygen delivery (CDO2). We hypothesized that CDO2
would be lower in newborns with CHD than normals.
Methods
We measured CBF and brain volume (BV) in 32 unse-
dated newborns (21 normals and 11 CHD) as part of an
IRB approved study using a 1.5T Siemens Avanto MRI.
CBF was measured according to a previously published
technique using a single PC acquisition prescribed per-
pendicular to both internal carotid arteries (ICA) and
basilar artery (BA) at the clivus level [3]. We also mea-
sured flows in the vertebral arteries (VA), common caro-
tid arteries (CCA) and internal jugular veins (IJV) using a
PC acquisition through the neck. Flows were quantified
and indexed to BV calculated from a high resolution 3D
T2W FSE acquisition. SaO2 and Hgb concentrations
were measured using conventional blood gases in order
to calculate: CDO2=SaO2×[Hgb]×1.36×CBF [4]. We
compared net and indexed CBF and CDO2 in the two
groups with an unpaired t-test with Welch’s correction
(Table 1). An analysis of CHD subgroups was also per-
formed. The relationship between CBF and gestational
age (GA) and agreement between BA vs VA flow sum
was examined using Pearson’s R.
Results
Subjects were scanned at a mean corrected GA of
40 weeks. MRI was performed prior to cardiac surgery in
all CHD subjects. The two groups had no difference in GA
(p=0.07). There were trends towards lower mean net and
indexed CBF in CHD newborns compared with controls
(control net CBF 138±14 vs CHD 118±10 ml/min
(p=0.26), control indexed CBF 0.341±0.027 vs CHD 0.321
±0.020 ml/min/mlBV (p=0.56)) (Table 1, Figure 1a,b). A
similar trend in mean net and indexed CDO2 was observed
in CHD newborns compared with controls (control net
CDO2 2749±284 vs CHD 2191±159 mlO2/min (p=0.1),
control indexed CDO2 6.81±0.54 vs CHD 5.99±0.31 mlO2/
min/mlBV (p=0.19)) (Figure 1c,d). In keeping with one pre-
vious study (3), CBF increased with GA (r=0.7, p=<0.0001).
The VA and BA flows were highly correlated (r=0.8,
p=0.0002), indicating good accuracy of the PC assessment
of CBF. There were no significant differences in measured
parameters between subgroups of CHD.
Conclusions
Although the differences between CBF and CDO2 in this
small sample of subjects were not statistically significant,
there was a clear trend towards lower values for both
parameters in CHD subjects. We propose that with a lar-
ger sample size, these differences will be significant, in
keeping with a demonstrable relationship between cere-
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Table 1 Table of mean values for all parameters measured, listed as mean ± SEM. P-values refer to comparisons of
each subject group to the control group. The CHD subgroups are as follows: single ventricle physiology (SV),
transposition of the great arteries (TGA), coarctation of the aorta (CoA), cyanotic and non-cyanotic CHD.






























364 ± 14 90 ± 2.9 15.4 ± 0.44 118 ± 10 0.26 2191 ± 159 0.10 0.321 ±
0.020
0.56 5.99 ± 0.31 0.19
SV (n=4) 364 ± 31 85 ± 6.4 15.5 ± 1.1 122 ± 22 0.58 2101 ± 299 0.15 0.328 ±
0.036
0.78 5.69 ± 0.49 0.15
TGA (n=4) 347 ± 13 89 ± 1.5 15.1 ± 0.38 113 ± 13 0.23 2058 ± 199 0.06 0.329 ±
0.041
0.82 5.97 ± 0.63 0.34
CoA (n=3) 385 ± 28 99 ±
0.67
15.8 ± 0.73 117 ± 20 0.46 2487 ± 382 0.61 0.301 ±
0.032
0.38 6.40 ± 0.59 0.63
Cyanotic
(n=7)
365 ± 14 85 ± 2.9 15.7 ± 0.46 124 ± 12 0.47 2198 ± 135 0.09 0.339 ±
0.027




361 ± 31 100 ±
0.5
15.0 ± 0.98 106 ± 18 0.22 2177 ± 411 0.29 0.290 ±
0.025
0.19 5.89 ± 0.66 0.31
Figure 1 CHD vs control comparisons of parameters plotted against corrected gestational age measured in weeks. a) Net cerebral blood flow
(ml/min) vs gestational age; b) Indexed cerebral blood flow to pre-operative brain volume (ml/min/mlBV) vs gestational age; c) Net cerebral
oxygen delivery (mlO2/min) vs gestational age; d) Indexed cerebral oxygen delivery to pre-operative brain volume (mlO2/min/mlBV) vs gestational
age. There is a trend in each parameter towards decreased values in CHD subjects compared to control.
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